Dr. Abdullah Mohammad Pervaiz, MD

Dr. Pervaiz practices at Baystate Medical Center in Springfield, Massachusetts.

Dr. Pervaiz's NPI, 1609308691, was assigned on March 30, 2017. Dr. Pervaiz holds South Carolina license 91410.

Dr. Pervaiz's primary practice is Baystate Medical Center, at 759 Chestnut St, Springfield, MA 01107 in Hampden County. The practice phone is (413) 794-0000.

Dr. Pervaiz's primary practice is Baystate Medical Center in Springfield, Massachusetts. Dr. Pervaiz is also affiliated with McLeod Regional Medical Center Florence. The medical group on file is MUSC Community Physicians. Dmand AI also links Dr. Pervaiz to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pervaiz practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Pervaiz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Pervaiz's licenses on file in 2 states: South Carolina and Massachusetts.

CMS data shows 580 Medicare services from Dr. Pervaiz across 10 procedure codes in 2024, for 302 Medicare patients. Medicare paid $25,846 for them.

CMS counts 302 Medicare patients who saw Dr. Pervaiz in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pervaiz's median patient age at 60, with 59% women.

In 2024, Dr. Pervaiz wrote 873 Medicare Part D claims for 238 patients. 80% of them were for generic drugs. CMS names the drug for 746 of them, across 14 drugs with 11 or more claims each, at $92,068 in total drug cost. In 2023, CMS named 215 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Pervaiz for performance year 2024, reported as part of a group. Dr. Pervaiz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of coronary angioplasty and stenting by Dr. Pervaiz, more than 37% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Pervaiz, published from 2019 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Coronary Stenosis. Dr. Pervaiz has published most often in Cureus. Dr. Pervaiz's most frequent co-authors are Anis John J. Kadado, MD, Kyle M. Gobeil, DO and Salman Bangash, MD.

CMS Open Payments shows 24 general payments to Dr. Pervaiz from 13 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 70% of the total. Abbott Laboratories paid the most, $803.